Analytical Data
-
基因名
ANKRD30A
- Application
-
别名
ANKRD30AAnkyrin repeat domain-containing Protein 30A; Serologically defined breast cancer antigen NY-BR-1
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BXX3
-
表达区间
948-1055aa
-
氨基酸序列
SEAKEIKSQLENQKVKWEQELCSVRLTLNQEEEKRRNADILNEKIREELGRIEEQHRKELEVKQQLEQALRIQDIELKSVESNLNQVSHTHENENYLLHENCMLKKEI
-
分子量
37.62 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ANKRD30A, a member of the ankyrin repeat domain protein family, has garnered attention in recent years due to its potential roles in various biological processes, including cellular signaling, immune response, and developmental regulation. The expression of ANKRD30A is often associated with specific cellular contexts, such as stress responses and inflammatory conditions, indicating its involvement in pathophysiological states. Studies have suggested that ANKRD30A may interact with key proteins in cell signaling pathways, thereby influencing downstream effects on cellular functions. This makes it a candidate for further investigation as a biomarker or therapeutic target in diseases such as cancer and autoimmune disorders. Research involving the recombinant expression of ANKRD30A has enabled scientists to study its structure and function in detail, ultimately leading to a better understanding of its role in physiological and pathological processes. Investigating the protein's interactions and mechanisms of action could provide insights into its contributions to human health and disease, paving the way for novel therapeutic strategies. Moreover, the recombinant production of ANKRD30A facilitates high-throughput screening and functional assays, accelerating its application in drug discovery and development. Overall, ongoing research into ANKRD30A is crucial for uncovering its biological significance and potential clinical applications.












